SMTL ID : 2a0c.1

Human CDK2 in complex with olomoucine II, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

monomer

Ligands

1 x CK9: 2-{[(2-{[(1R)-1-(HYDROXYMETHYL)PROPYL]AMINO}-9-ISOPROPYL-9H-PURIN-6-YL)AMINO]METHYL}PHENOL(Non-covalent)

CK9.1: 19 residues within 4Å: Chain A: I.10, G.11, E.12, G.13, V.18, A.31, F.80, E.81, F.82, L.83, H.84, Q.85, D.86, K.89, Q.131, N.132, L.134, A.144, D.145 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:I.10, A:V.18, A:V.18, A:A.31, A:F.80, A:F.82, A:L.134, A:A.144 Hydrogen bonds: A:I.10, A:L.83, A:L.83, A:D.86, A:K.89 pi-Cation interactions: A:K.89

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Krystof, V. et al., Antiproliferative activity of olomoucine II, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitor. Cell.Mol.Life Sci. (2005)

Release Date

2006-01-24

Peptides

Cell division protein kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
X

Cell division protein kinase 2

Related Entries With Identical Sequence